Prophylaxis of infection and effects on osseointegration using a tobramycin-periapatite coating on titanium implants - An experimental study in the rabbit

Journal of Orthopaedic Research

Volumn 27, Issue 6, 2009, Pages 710-716

  Moojen, Dirk Jan F ^a   Vogely, H Charles ^a   Fleer, André ^a   Nikkels, Peter G J ^a   Higham, Paul A ^b   Verbout, Abraham J ^a   Castelein, René M ^a   Dhert, Wouter J A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b STRYKER ORTHOPAEDICS   (United States)

Author keywords

Osseointegration; Prophylaxis of infection; Titanium implants; Tobramycin periapatite coating

Indexed keywords

HYDROXYAPATITE; TITANIUM; TOBRAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIOLOGY; BACTERIUM CONTAMINATION; BONE REGENERATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; IMPLANT; INFECTION PREVENTION; MATERIAL COATING; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TIBIA;

ANIMALS; ANTI-BACTERIAL AGENTS; APATITES; BONE NAILS; COATED MATERIALS, BIOCOMPATIBLE; FEMALE; OSSEOINTEGRATION; PROSTHESIS-RELATED INFECTIONS; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TITANIUM; TOBRAMYCIN;

EID: 66249122033     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20808     Document Type: Article

References (22)

1. Rajaratnam SS, Jack C, Tavakkolizadeh A, et al. 2008. Long-term results of a hydroxyapatite-coated femoral component in total hip replacement: a 15- to 21-year follow-up study. J Bone Joint Surg Br 90:27-30.
2. Hallan G, Lie SA, Furnes O, et al. 2007. Medium- and long-term performance of 11 516 uncemented primary femoral stems from the Norwegian arthroplasty register. J Bone Joint Surg Br 89:1574-1580.
3. Vogely HC, Oosterbos CJ, Puts EW, et al. 2000. Effects of hydroxyapatite coating on Ti-6A1-4V implant-site infection in a rabbit tibial model. J Orthop Res 18:485-493. (Pubitemid 30599627)
4. Oosterbos CJ, Vogely H, Nijhof MW, et al. 2002. Osseointegration of hydroxyapatite-coated and noncoated Ti6Al4V implants in the presence of local infection: a comparative histomorphometrical study in rabbits. J Biomed Mater Res 60:339-347. (Pubitemid 34296802)
5. Nijhof MW, Dhert WJ, Fleer A, et al. 2000. Prophylaxis of implant-related staphylococcal infections using tobramycin-containing bone cement. J Biomed Mater Res 52:754-761.
6. Engesaeter LB, Lie SA, Espehaug B, et al. 2003. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 74:644-651. (Pubitemid 38067862)
7. An YH, Bradley J, Powers DL, et al. 1997. The prevention of prosthetic infection using a cross-linked albumin coating in a rabbit model. J Bone Joint Surg Br 79:816-819.
8. Campbell AA, Song L, Li XS, et al. 2000. Development, characterization, and anti-microbial efficacy of hydroxyapatite-chlorhexidine coatings produced by surface-induced mineralization. J Biomed Mater Res 53:400-407. (Pubitemid 30608804)
9. DeJong ES, DeBerardino TM, Brooks DE, et al. 2001. Antimicrobial efficacy of external fixator pins coated with a lipid stabilized hydroxyapatite/ chlorhexidine complex to prevent pin tract infection in a goat model. J Trauma 50:1008-1014. (Pubitemid 32591758)
10. Darouiche RO, Mansouri MD, Zakarevicz D, et al. 2007. In vivo efficacy of antimicrobial-coated devices. J Bone Joint Surg Am 89:792-797.
11. Dunn DS, Raghavan S, Volz RG. 1993. Gentamicin sulfate attachment and release from anodized Ti-6A1-4V orthopedic materials. J Biomed Mater Res 27:895-900. (Pubitemid 23178665)
12. Gollwitzer H, Ibrahim K, Meyer H, et al. 2003. Antibacterial poly(D,L-lactic acid) coating of medical implants using a biodegradable drug delivery technology. J Antimicrob Chemother 51:585-591. (Pubitemid 36336150)
13. Lucke M, Schmidmaier G, Sadoni S, et al. 2003. Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone 32:521-531. (Pubitemid 39665711)
14. Price JS, Tencer AF, Arm DM, et al. 1996. Controlled release of antibiotics from coated orthopedic implants. J Biomed Mater Res 30:281-286. (Pubitemid 26071916)
15. Stigter M, Bezemer J, De Groot K, et al. 2004. Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J Control Release 99:127-137. (Pubitemid 39165739)
16. Antoci V Jr, King SB, Jose B, et al. 2007. Vancomycin covalently bonded to titanium alloy prevents bacterial colonization. J Orthop Res 25:858-866. (Pubitemid 47046432)
17. Kalicke T, Schierholz J, Schlegel U, et al. 2006. Effect on infection resistance of a local antiseptic and antibiotic coating on osteosynthesis implants: an in vitro and in vivo study. J Orthop Res 24:1622-1640. (Pubitemid 44203294)
18. Alt V, Bitschnau A, Osterling J, et al. 2006. The effects of combined gentamicin-hydroxyapatite coating for cementless joint prostheses on the reduction of infection rates in a rabbit infection prophylaxis model. Biomaterials 26:4627-4634. (Pubitemid 43783227)
19. Moojen DJ, Vogely HC, Fleer A, et al. 2005. Release of gentamycin and tobramycin from PeriApatite-coated titanium foam implants. In: 51st Annual Meeting of the Orthopaedic Research Society, Washington, DC.
20. Nijhof MW, Stallmann HP, Vogely HC, et al. 2000. Prevention of infection with tobramycin-containing bone cement or systemic cefazolin in an animal model. J Biomed Mater Res 52:709-715.
21. Zimmerli W, Waldvogel FA, Vaudaux P, et al. 1982. Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis 146:487-497.
22. Lode H. 1998. Tobramycin: a review of therapeutic uses and dosing schedules. Curr Therapeut Res 59:420-453. (Pubitemid 28361841)